<DOC>
	<DOCNO>NCT02960074</DOCNO>
	<brief_summary>This Phase I trial evaluate safety efficacy fecal microbiota transplantation ( FMT ) treatment peanut allergy . In research investigator would like learn way treat peanut allergy . There currently know cure peanut allergy . The primary aim ass safety tolerability oral FMT patient peanut allergy age 18-40 year .</brief_summary>
	<brief_title>Evaluating Safety Efficacy Fecal Microbiota Transplant Peanut Allergic Patients</brief_title>
	<detailed_description>This study fecal microbiota transplantation ( FMT ) treatment peanut allergy . The primary aim ass safety tolerability oral FMT patient peanut allergy age 18-40 year . A total 10 patient peanut allergy enrol fail screening food challenge peanut . Participating give oral encapsulate frozen FMT 2 day . Patients undergo second third food challenge receive FMT . The expected duration study subject one year . Stool collection , skin test blood sample do serially .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<criteria>1 . Allergic reaction food challenge 3 mg 100 mg peanut protein . 2 . Positive SPT 5 mm wheal peanut and/or positive peanutspecific IgE &gt; 0.35kU/L . 3 . Spirometry/Peak Flow Measurement FEV1 &gt; =80 % predict . 4 . Negative Hepatitis B , Hepatitis C , Human Immunodeficiency Virus . 5 . Negative urine pregnancy test female participant . 6 . Will use acceptable doublebarrier form birth control study . 7 . Able swallow 2 empty capsule size 00 . 8 . Able give inform consent . 9 . Willing able participate study requirement . 10 . Willing undergo telephone followup . 1 . History severe anaphylaxis . 2 . Required one dose epinephrine treat allergic reaction . 3 . Other food allergy exclude peanut tree nut . 4 . Patients gelatin allergy 5 . Chronic illness control asthma , mild eczema , allergic rhinitis . 6 . Infections necessitate frequent systemic antibiotic . 7 . History chronic immunosuppressive therapy . 8 . History chronic disease , except atopic condition . 9 . More one episode allergic nonallergic urticaria within 2 month span time , history consistent poorly control persistent asthma . 10 . Previous participation peanut immunotherapy protocol aeroallergen immunotherapy maintenance therapy le 6 month receive Omalizumab therapy past year . 11 . Women pregnant breast feeding , plan get pregnant time study . 12 . Sexually active female patient refuse use contraception study . 13 . GI condition include inflammatory bowel disease eosinophilic esophagitis , food protein induce enterocolitis , reflux , constipation , esophageal dysmotility , swallow dysfunction , delay gastric empty syndrome , pill esophagitis history aspiration pneumonia within 3 month prior screen . 14 . History rheumatologic condition . 15 . Direct relative inflammatory bowel disease . 16 . Patients form immunodeficiency . 17 . Patients participate plan participate next year , participate within prior year interventional trial investigational drug therapy administer . 18 . Positive Hepatitis B , Hepatitis C , Human Immunodeficiency Virus . 19 . Systemic antibiotic therapy past 6 month systemic corticosteroid therapy past 3 month . 20 . Allergic reaction food challenge 1 mg peanut protein .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Allergy , Peanut</keyword>
	<keyword>Hypersensitivity Peanut</keyword>
	<keyword>Peanut Allergy</keyword>
	<keyword>Donor Feces Infusion</keyword>
	<keyword>Fecal Transplant</keyword>
	<keyword>Fecal Transplantation</keyword>
	<keyword>Intestinal Microbiota Transfer</keyword>
	<keyword>Fecal Microbiota Transplantation</keyword>
	<keyword>Food allergy</keyword>
</DOC>